Clinical trials
Glioblastoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 7 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Recruiting | 16 |
| Active, not recruiting | 8 |
| Terminated | 8 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| Institute of Cancer Research, United Kingdom | 5 |
| University College, London | 5 |
| AstraZeneca | 4 |
| Hoffmann-La Roche | 4 |
| AbbVie | 3 |
| Cancer Research UK | 3 |
| Novartis Pharmaceuticals | 3 |
| Bayer | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 83 |
| Brain Neoplasms | 25 |
| Glioma | 16 |
| Gliosarcoma | 16 |
| Astrocytoma | 12 |
| Central Nervous System Neoplasms | 12 |
| Neoplasms | 12 |
| Oligodendroglioma | 8 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Melanoma | 5 |
Trials
Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.